A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record

BMC Medical Informatics and Decision Making

Volumn 14, Issue 1, 2014, Pages

  Onitilo, Adedayo A ^a,b   Stankowski, Rachel V ^a   Berg, Richard L ^a   Engel, Jessica M ^a   Williams, Gail M ^b   Doi, Suhail A ^b  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cancer; Electronic medical record; Method; Pre diabetes; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD; COHORT ANALYSIS; COMORBIDITY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRODROMAL SYMPTOM; STATISTICS; TIME; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PRODROMAL SYMPTOMS; TIME FACTORS; WISCONSIN;

EID: 84901017446     PISSN: None     EISSN: 14726947     Source Type: Journal    
DOI: 10.1186/1472-6947-14-38     Document Type: Article

References (37)

1. Cancer treatment and survivorship statistics, 2012. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E, CA Cancer J Clin 2012 62 4 220 241 10.3322/caac.21149 22700443
2. American Cancer Society, Cancer Facts and Figures 2012 Atlanta (GA): American Cancer Society 2012
3. Centers for Disease Control and Prevention, National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2011 http://www.cdc.gov/diabetes/ pubs/pdf/ndfs-2011.pdf
4. Diabetes mellitus among cancer survivors. Stava CJ, Beck ML, Feng L, Lopez A, Busaidy N, Vassilopoulou-Sellin R, J Cancer Surviv 2007 1 2 108 115 10.1007/s11764-007-0016-z 18648951
5. Diabetes and cancer. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R, Endocr Relat Cancer 2009 16 4 1103 1123 10.1677/ERC-09-0087 19620249
6. Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment. Ko CY, Maggard M, Livingston EH, J Surg Res 2003 114 1 1 5 10.1016/S0022-4804(03)00167- 7 13678691 (Pubitemid 37108668)
7. Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. Thong MS, van de Poll-Franse L, Hoffman RM, Albertsen PC, Hamilton AS, Stanford JL, Penson DF, BJU Int 2011 107 8 1223 1231 10.1111/j.1464-410X.2010.09861.x 21070583
8. Looking beyond recurrence: comorbitidies in cancer survivors. Edgington A, Morgan MA, Clin J Oncol Nurs 2011 15 1 3 E12 10.1188/11.CJON.E3-E12 21278033
9. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Khan NF, Mant D, Carpenter L, Forman D, Rose PW, Br J Cancer 2011 105 Suppl 1 29 S37 22048030
10. Diabetes and cancer I: risk, survival, and implications for screening. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA, Cancer Causes Control 2012 23 6 967 981 10.1007/s10552-012-9972-3 22552844
11. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer. Ferguson RS, Gallagher EJ, Scheinman EJ, Damouni RR, LeRoith D, Vitam Horm 2013 93 51 98 23810003
12. The links between insulin resistance, diabetes, and cancer. Orgel E, Mittelman SD, Curr Diab Rep 2013 13 2 213 222 10.1007/s11892-012-0356-6 23271574
13. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA, Cancer Causes Control 2012 23 7 991 1008 10.1007/s10552-012-9971-4 22527174
14. Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Johnson JA, Bowker SL, Diabetologia 2011 54 1 25 31 10.1007/s00125-010-1933-3 20959956
15. Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fata cancer at some other sites: the Paris Prospective Study. Balkau B, Kahn HS, Courbon D, Eschwège E, Ducimetière P, Paris Prospective Study, Diabetes Care 2001 24 5 843 849 10.2337/diacare.24.5.843 11347741 (Pubitemid 33636056)
16. Plasma C-peptide, mammographic breast density, and risk of invasive breats cancer. Ahern TP, Hankinson SE, Willet WC, Pollak MN, Eliassen AH, Tamimi RM, Cancer Epidemiol Biomarkers Prev 2013 22 10 1786 1796 10.1158/1055-9965. EPI-13-0375 24097198
17. Hyperglycemia, insulin resistance, impaired pancreated β-cell function, and risk of pancreatic cancer. Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, Stampfer MJ, Sato K, Ma J, Buring JE, Sesso HD, Lee IM, Gaziano JM, McTiernan A, Phillips LS, Chochrane BB, Pollak MN, Manson JE, Giovannucci EL, Fuchs CS, J Natl Cancer Inst 2013 105 14 1027 1035 10.1093/jnci/djt123 23847240
18. Circulating insulin and c-peptide levels and risk of breast cancer among predominantly premenopausal women. Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE, Cancer Epidemiol Biomarkers Prev 2007 16 1 161 164 10.1158/1055-9965.EPI-06-0693 17220346 (Pubitemid 46174280)
19. Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Wilke RA, Berg RL, Peissig P, Kitchner T, Sijercic B, McCarty CA, McCarty DJ, Clin Med Res 2007 5 1 1 7 10.3121/cmr.2007.726 17456828 (Pubitemid 350218773)
20. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2010 33 Suppl 1 62 S69 20042775
21. Epidemiologic research in an integrated regional medical care system: the Marshfield Epidemiologic Study Area. DeStefano F, Eaker ED, Broste SK, Nordstrom DL, Peissig PL, Vierkant RA, Konitzer KA, Gruber RL, Layde PM, J Clin Epidemiol 1996 49 6 643 652 10.1016/0895-4356(96)00008-X 8656225 (Pubitemid 26202692)
22. Quantifying the duration of pre-diabetes. Bertram MY, Vos T, Aust N Z J Public Health 2010 34 3 311 314 10.1111/j.1753-6405.2010.00532.x 20618275
23. Identifying persons with diabetes using Medicare claims data. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM, Am J Med Qual 1999 14 6 270 277 10.1177/106286069901400607 10624032
24. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Hux JE, Ivis F, Flintoft V, Bica A, Diabetes Care 2002 25 3 512 516 10.2337/diacare.25.3.512 11874939 (Pubitemid 41103345)
25. Electronic health record use to classify patients with newly diagnosed versus preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management. Kudyakov R, Bowen J, Ewen E, West SL, Daoud Y, Fleming N, Masica A, Popul Health Manag 2012 15 1 3 11 10.1089/pop.2010.0084 21877923
26. Who are your patients with diabetes?: EMR case definitions in the Canadian primary care setting. Greiver M, Keshavjee K, Martin K, Aliarzadeh B, Can Fam Physician 2012 58 7 804 e421-422 22798469
27. A bootstrapping algorithm to improve cohort identification using structure data. Kandula S, Zeng-Treitler Q, Chen L, Salomon WL, Bray BE, J Biomed Inform 2011 44 Suppl 1 63 S68 22079803
28. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R, Diabetes Care 2013 36 4 914 921 10.2337/dc12-0964 23193215
29. Automatically detecting problem list omissions of type 2 diabetes cases using electronic medical records. Pacheco JA, Thompson W, Kho A, AMIA Annu Symp Proc 2011 2011 1062 1069 22195167
30. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. Km N, Peissig PL, Kho AN, Bielinski SJ, Berg RL, Choudhary V, Basford M, Chute CG, Kullo IJ, Li R, Pacheco JA, Rasmussen LV, Spangler L, Denny JC, J Am Med Inform Assoc 2013 20 e1 147 e154 10.1136/amiajnl-2012-000896 23531748
31. Diabetes screening with hemoglobin A1c prior to a change in guidelines recommendations: prevalence and patient characteristics. Greiver M, Aliarzadeh B, Moineddin R, Meaney C, Ivers N, BMC Fam Pract 2011 12 91 10.1186/1471-2296- 12-91 21864396
32. Metformin and the risk of cancer: time-related biases in observational studies. Suissa S, Azoulay L, Diabetes Care 2012 35 12 2665 2673 10.2337/dc12-0788 23173135
33. The inevitable application of big data to health care. Murdoch TB, Detsky AS, JAMA 2013 309 13 1351 1352 10.1001/jama.2013.393 23549579
34. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA, Eur J Cancer Prev 2013 23 2 76 83
35. Prostate cancer risk in pre-diabetic men: a matched cohort study. Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich I, Williams GM, Doi SA, Clin Med Res 2013 11 4 201 9 10.3121/cmr.2013.1160 23656798
36. Increased risk of colon cancer in men in the pre-diabetes phase. Onitilo AA, Berg RL, Engel JM, Glurich I, Stankowski RV, Williams G, Doi SA, PLoS One 2013 8 8 70426 10.1371/journal.pone.0070426 23936428
37. Type 2 diabetes mellitus, glycemic control, and cancer risk. Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, Doi SA, Eur J Cancer Prev 2013 23 2 134 140